Connection

HUDA ZOGHBI to Neurodegenerative Diseases

This is a "connection" page, showing publications HUDA ZOGHBI has written about Neurodegenerative Diseases.
Connection Strength

2.398
  1. Pathogenesis of polyglutamine diseases: Piecing together a complex molecular puzzle. J Exp Med. 2026 Jan 05; 223(1).
    View in: PubMed
    Score: 0.763
  2. Mouse and fly models of neurodegeneration. Trends Genet. 2002 Sep; 18(9):463-71.
    View in: PubMed
    Score: 0.153
  3. The role of chaperones in polyglutamine disease. Trends Mol Med. 2002 May; 8(5):232-6.
    View in: PubMed
    Score: 0.150
  4. Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice. Hum Mol Genet. 2001 Jul 01; 10(14):1511-8.
    View in: PubMed
    Score: 0.141
  5. Glutamine repeats and neurodegeneration. Annu Rev Neurosci. 2000; 23:217-47.
    View in: PubMed
    Score: 0.127
  6. Insights from mouse models into the molecular basis of neurodegeneration. Annu Rev Physiol. 2000; 62:779-802.
    View in: PubMed
    Score: 0.127
  7. Expanding our understanding of polyglutamine diseases through mouse models. Neuron. 1999 Nov; 24(3):499-502.
    View in: PubMed
    Score: 0.126
  8. Polyglutamine diseases: protein cleavage and aggregation. Curr Opin Neurobiol. 1999 Oct; 9(5):566-70.
    View in: PubMed
    Score: 0.125
  9. Antisense oligonucleotide-mediated ataxin-1 reduction prolongs survival in SCA1 mice and reveals disease-associated transcriptome profiles. JCI Insight. 2018 11 02; 3(21).
    View in: PubMed
    Score: 0.118
  10. Disruption of the ATXN1-CIC complex causes a spectrum of neurobehavioral phenotypes in mice and humans. Nat Genet. 2017 Apr; 49(4):527-536.
    View in: PubMed
    Score: 0.105
  11. Neurodegeneration: From cellular concepts to clinical applications. Sci Transl Med. 2016 11 09; 8(364):364ps18.
    View in: PubMed
    Score: 0.102
  12. Pumilio1 haploinsufficiency leads to SCA1-like neurodegeneration by increasing wild-type Ataxin1 levels. Cell. 2015 Mar 12; 160(6):1087-98.
    View in: PubMed
    Score: 0.091
  13. dAtaxin-2 mediates expanded Ataxin-1-induced neurodegeneration in a Drosophila model of SCA1. PLoS Genet. 2007 Dec 28; 3(12):e234.
    View in: PubMed
    Score: 0.055
  14. A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration. Cell. 2006 May 19; 125(4):801-14.
    View in: PubMed
    Score: 0.050
  15. Diseases of unstable repeat expansion: mechanisms and common principles. Nat Rev Genet. 2005 Oct; 6(10):743-55.
    View in: PubMed
    Score: 0.047
  16. A long CAG repeat in the mouse Sca1 locus replicates SCA1 features and reveals the impact of protein solubility on selective neurodegeneration. Neuron. 2002 Jun 13; 34(6):905-19.
    View in: PubMed
    Score: 0.038
  17. Enhanced SUMOylation in polyglutamine diseases. Biochem Biophys Res Commun. 2002 Apr 26; 293(1):307-13.
    View in: PubMed
    Score: 0.037
  18. Identification of genes that modify ataxin-1-induced neurodegeneration. Nature. 2000 Nov 02; 408(6808):101-6.
    View in: PubMed
    Score: 0.034
  19. Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell. 1998 Oct 02; 95(1):41-53.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.